The estimated Net Worth of Alec Barclay is at least $1.38 millió dollars as of 8 April 2022. Mr. Barclay owns over 12,951 units of T2 Biosystems Inc stock worth over $418,471 and over the last 7 years he sold TTOO stock worth over $23,239. In addition, he makes $937,834 as Chief Operating Officer at T2 Biosystems Inc.
Alec has made over 10 trades of the T2 Biosystems Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 12,951 units of TTOO stock worth $6,476 on 8 April 2022.
The largest trade he's ever made was exercising 168,488 units of T2 Biosystems Inc stock on 24 February 2022 worth over $387,522. On average, Alec trades about 17,727 units every 81 days since 2018. As of 8 April 2022 he still owns at least 181,944 units of T2 Biosystems Inc stock.
You can see the complete history of Mr. Barclay stock trades at the bottom of the page.
Alec Barclay serves as Chief Operating Officer of the Company. He has served as our Senior Vice President, Operations since March 2018. Mr. Barclay joined our company in April 2016 as Vice President of Product Development and Product Management. Mr. Barclay joined our company in April 2016 as Vice President of Product Development and Program Management. Prior to joining the Company, Mr. Barclay served as the Director of Hardware and Systems Engineering at Becton Dickinson, a medical technology company that manufactures and sells medical devices, instrument systems, and reagents, within their Genomics division from January 2015 to April 2016. Prior to joining Becton Dickinson, he held various positions within Siemens Healthcare from July 2006 to December 2014, with his last assignment serving as Senior Manager, Lead Systems Integrator. Mr. Barclay received his BSME from Rochester Institute of Technology.
As the Chief Operating Officer of T2 Biosystems Inc, the total compensation of Alec Barclay at T2 Biosystems Inc is $937,834. There are 1 executives at T2 Biosystems Inc getting paid more, with John McDonough having the highest compensation of $1,637,480.
Alec Barclay is 39, he's been the Chief Operating Officer of T2 Biosystems Inc since 2019. There are 18 older and no younger executives at T2 Biosystems Inc. The oldest executive at T2 Biosystems Inc is John Cumming, 74, who is the Lead Independent Director.
Alec's mailing address filed with the SEC is 101, Hartwell Avenue, Lexington, Middlesex County, Massachusetts, 02421, United States.
Over the last 10 years, insiders at T2 Biosystems Inc have traded over $18,971,153 worth of T2 Biosystems Inc stock and bought 5,875,341 units worth $59,722,018 . The most active insiders traders include Adrian M Jones, Group L.P.Crg Partners Iii ... és Thomas J. Carella. On average, T2 Biosystems Inc executives and independent directors trade stock every 20 days with the average trade being worth of $764,499. The most recent stock trade was executed by John J Iii Sperzel on 24 February 2024, trading 67 units of TTOO stock currently worth $154.
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Inc executives and other stock owners filed with the SEC include: